Allergic rhinoconjunctivitis in children

British Medical Journal

Volumn 335, Issue 7627, 2007, Pages 985-988

  De Groot, Hans ^a   Brand, Paul L P ^b   Fokkens, Wytske F ^c   Berger, Marjolein Y ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ISALA HOSPITAL   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BECLOMETASONE; BUDESONIDE; CETIRIZINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; FLUTICASONE; GLUCOCORTICOID; GRASS POLLEN EXTRACT; HOUSE DUST ALLERGEN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LORATADINE; MOMETASONE FUROATE; MONTELUKAST; OMALIZUMAB; PETROLATUM; POLLEN ANTIGEN; STEROID; TRIAMCINOLONE;

ALLERGIC RHINITIS; ALLERGY TEST; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; ENDOSCOPY; EPISTAXIS; GROWTH RETARDATION; HUMAN; IMMUNOTHERAPY; PATHOGENESIS; PET ANIMAL; PHYSICAL EXAMINATION; PREVALENCE; PRICK TEST; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; RHINOCONJUNCTIVITIS; SKIN TEST; SYSTEMATIC REVIEW;

ALLERGENS; CHILD; CONJUNCTIVITIS, ALLERGIC; DIAGNOSIS, DIFFERENTIAL; GLUCOCORTICOIDS; HISTAMINE H1 ANTAGONISTS; HUMANS; IMMUNOTHERAPY; PHYSICAL EXAMINATION; QUALITY OF LIFE;

EID: 36348983810     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39365.617905.BE     Document Type: Review

References (31)

1. Baatenburg de Jong A, Rijdt JP te, Brand PLP. Cough and malaise in young children due to allergic rhinoconjunctivitis. [In Dutch.] Ned Tijdschr Geneeskd 2005;149:1545-8.
2. Kocevar Sazonov V, Thomas J, Jonsson L, Valovirta E, Kristensen F, Yin DD, et al. Association between allergic rhinitis and hospital resource use among asthmatic children in Norway. Allergy 2005;60:338-42.
3. Hakansson K, Thomsen SF, Ulrik CS, Porsbjerg C, Backer V. Increase in the prevalence of rhinitis among Danish children from 1986 to 2001. Pediatr Allergy Immunol 2007;18:154-9.
4. Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 2006;368:733-43.
5. Arshad SH, Kurukulaaratchy RJ, Fenn M, Waterhouse L, Matthews S. Rhinitis in 10-year old children and early life risk factors for its development. Acta Paediatr 2002;91:1334-8.
6. Fokkens W, Lund V, Bachert C, Clement P, Helllings P, Holmstrom M, et al. EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy 2005;60:583-601.
7. Gendo K, Larson EB. Evidence-based diagnostic strategies for evaluating suspected allergic rhinitis. Ann Intern Med 2004;140:278-89.
8. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(5 suppl):S147-334.
9. Juniper EF, Howland WC, Roberts NB, Thompson AK, King DR. Measuring quality of life in children with rhinoconjunctivitis. J Allergy Clin Immunol 1998;101:163-70.
10. Bouquet J, van Cauwenberge P, Ait Khaled N, Bachert C, Baena-Cagnani CE, Bouchard J, et al. Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN). Allergy 2006;61:1086-96.
11. Custovic A, Gerth van Wijk R. The effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma: ARIA update (in collaboration with Ga2len). Allergy 2005;60:1112-5.
12. Morgan WJ, Crain EF, Gruchalla RS, O'Connor GT, Kattan M, Evans R, et al. Inner-City Asthma Study Group. Results of a home-based environmental intervention among urban children with asthma. N Engl J Med 2004;351:1068-80.
13. Sheikh A, Hutwitz B, Shehata Y. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst Rev 2007;(1):CD001563.
14. Terreehorst I, Hak E, Oosting AJ, Tempels-Pavlica Z, de Monchy JGR, Bruijzeel-Koomen CAAM, et al. Evaluation of impermeable covers for bedding in patients with allergic rhinitis. N Engl J Med 2003;349:237-46.
15. Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 1998;317:1624-9.
16. Al Sayyad JJ, Fedorowicz Z, Alhashimi D, Jamal A. Topical nasal steroids for intermittent and persistent allergic rhinitis in children. Cochrane Database Syst Rev 2007;(1):CD003163.
17. Waddell AN, Patel SK, Toma AG, Maw AR. Intranasal steroid sprays in the treatment of rhinitis: is one better than another? J Laryngol Otol 2003;117:843-5.
18. Allen DB, Meltzer EO, Lemanske RF Jr, Philpot EE, Faris MA, Kral KM, et al. No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year. Allergy Asthma Proc 2002;23:407-13.
19. Schenkel EJ, Skoner DP, Bronsky EA, Miller SD, Pearlman DS, Rooklin A, et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics 2000;105:E22.
20. Murphy K, Uryniak T, Simpson B, O'Dowd L. Growth velocity in children with perennial allergic rhinitis treated with budesonide aqueous nasal spray. Ann Allergy Asthma Immunol 2006;96:723-30.
21. Möller C, Ahlström H, Henricson KA, Akerlund A, Hildebrand H. Safety of nasal budesonide in the long-term treatment of children with perennial rhinitis. Clin Exp Allergy 2003;33:816-22.
22. Sheth KK, Cook CK, Philpot EE, Prillaman BA, Witham LA, Faris MA, et al. Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function. Allergy Asthma Proc 2004;25:115-20.
23. Skoner DP, Rachelefsky GS, Meltzer EO, Chervinsky P, Morris RM, Seltzer JM, et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics 2000;105:E23.
24. Simons FER, Simons SJ. Levocetirizine: pharmacokinetics and pharmacodynamics in children aged 6to 11 years. J Allergy Clin Immunol 2005;116:355-61.
25. Razi C, Bakirtas A, Harmanci K, Turktas I, Erbas D. Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2006;97:767-74.
26. Röder E, Berger MY, de Groot H, Gerth van Wijk R. Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review. Pediatr Allergy Immunol 2007 (in press).
27. Sopo SM, Macchiaiolo M, Zorzi G, Tripodi S. Sublingual immunotherapy in asthma and rhinoconjunctivitis; systematic review of paediatric literature. Arch Dis Child 2004;89:620.
28. Cox LS, Linnemann DL, Nolte H, Weldon D, Hnegold I, Nelson HS. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 2006;117:1021-35.
29. Wilson DR, Torres Lima M, Durham SR. Sublingual immunotherapy forallergic rhinitis. Cochrane Database Syst Rev 2003;(2):CD002893.
30. Röder E, Berger MY, Hop WC, Bernsen RM, de Groot H, Gerth van Wijk R. Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care. J Allergy Clin Immunol 2007;119:892-8.
31. Dykewicz MS, Fineman S, Skoner DP, Nicklas R, Lee R, Blessing-Moore J, et al. Diagnosis and management of rhinitis: complete guidelines of the joint task force on practice parameters in allergy, asthma and immunology. Ann Allergy Asthma Immunol 1998;81:478-518.